Immune Reaction Articles & Analysis
10 news found
In fact, ExcellGene demonstrated that a single 40 L bioreactor based production run can provide antigens in sufficient quantity to immunize about 5 million people, i.e. half of the Swiss population. Most promising data were shared on an ExcellGene patented principle for generating chimaeric antigens. ...
It can be used not only as an indicator in biochemical reactions but also as a labeling reagent in immune reactions (especially ELISA) and is a key raw material for enzyme-labeled antibodies. ...
Toddlers often have more severe reactions, displaying all symptoms of an allergic reaction including vomiting. ...
Invizius Limited (“Invizius”), a biotechnology company developing treatments to suppress unwanted immune responses in haemodialysis, today announces that it has been awarded a second Biomedical Catalyst grant (Feasibility & Primer Award) by Innovate UK to research a new field of application for its H-Guard technology. ...
The goal of any vaccine is to generate immunity to pathogens, in order to reduce the spread of infectious diseases. ...
In the NNCIT-02 study, brittle diabetes patients being transplanted with islets of Langerhans are treated with IBSOLVMIR® which has shown to be able to address the instant blood-mediated inflammatory reaction (IBMIR) occurring as an innate immune reaction to the infusion of transplanted cells. ...
However, there is a much greater need for research into implants that are intended to replace elastic tissue, because the demands on the materials are high: they must retain their mechanical properties for many years, be 100 percent resistant and biocompatible, and must not cause rejection reactions by the immune system. The latter is particularly important for ...
Serious adverse reactions occurred in 35% of patients receiving BAVENCIO in combination with axitinib. ...
Formaldehyde in fabrics can cause allergic reactions for some people and several major international institutions have labeled formaldehyde as a known human carcinogen. ...
The study will utilize polymerase chain reaction (PCR) to evaluate the levels of Trypanosoma cruzi in blood samples as the primary endpoint for response to treatment. ...
